Skip to main content

Table 1 Literature summary of medical applications of MNPs in recent 20 years

From: Application of magnetic nanoparticles in cell therapy

 

MNP

Core size (nm)

Carrier

Disease

Function

References

1

CoFe2O4

10

Cell

[13]

2

Endorem

3–5

Cell

Vascular injury

MT

[4]

3

γ-Fe2O3

7 & 9

Liposome

Cancer

MT and hyperthermia and MRI

[14]

4

Fe3O4

10

Liposome

MT

[15]

5

Fe3O4

6.8 ± 1.36

Liposome

Tumor

MT

[16]

6

Fe3O4

30–40

Microglial BV2 cells

Magnetic hyperthermia

[17]

7

Fe3O4

10

Hydrogel vesicle

Drug delivery

[18]

8

γ-Fe2O3

8

Liposome

Prostatic adenocarcinoma

MT

[19]

9

γ-Fe2O3

8

Microvesicle

MRI and MT

[20]

10

19 ± 3

Cancer

Magnetic hyperthermia

[11]

11

NPs

5 /10

Liposome

Delivery

[12]

12

Fe3O4

16 ± 4

Liposome

MRI

[21]

13

Fe3O4

200

EV

Myocardial infarction

MT

[22]

14

Fe3O4

100

Exosome

Wound healing

MT

[23]

15

VivoTrax

Exosome

Tumor

MPI

[24]

16

Fe3O4

 10

Exosome

Cancer

MT

[25]

17

Fe3O4

 10

Exosome

Tumor

MT and delivery

[26]

18

Fe3O4

< 60

Exosome

Wound healing

MT

[27]

19

SPION

10

Exosome

Cancer

Delivery

[28]

20

Fe3O4

8

Exosome

Glycuresis

MT

[29]

21

Fe3O4

20 & 200

MSC

Trabecular meshwork

MT

[30]

22

SPION

6.2

MSC

Spinal cord injury

MT

[31, 32]

23

ZnFe2O4

18.93 ± 1.6

MSC

Cancer

Magnetic hyperthermia

[33]

24

Fe3O4

6–7

MSC

MRI

[34]

25

Fe3O4

8

ESC

MT

[35]

26

Fe3O4

6.6

ADSC

Osteoporosis

MT

[36]

27

Fe3O4

10

MSC

Angiogenesis

MT

[37]

28

Fe3O4

10

hMSC

MRI and MT

[38]

29

γ-Fe2O3

1.7–11.5

MSC

Pulmonary damage

MT

[39]

30

SPION

10

ADSC

Parkinson

MT

[40]

31

Zn0.4Fe2.6O4

15

NSC

Brain stroke

MT

[41]

32

IONP

 22

H9C2

Myocardial infarction

MT

[42]

33

IONP

12

Exosome

Spinal cord injury

MT

[43]

34

IONP

12

Exosome

Ischemic stroke

MT

[44]

35

IONP

20–30

Exosome

Myocardial infarction

MT

[45]

36

Fe3O4

5

Exosome

Tumor

Photothermal therapy

[46]

  1. –The relevant information was not found